teresita padilla-benavides
Wesleyan University
Middletown, United States
Review Editor
Anti-Cancer Drugs
Wesleyan University
Middletown, United States
Review Editor
Anti-Cancer Drugs
Stanford Cardiovascular Institute
Stanford, United States
Review Editor
Cardiovascular and Hematologic Drugs
University College Dublin
Dublin, Ireland
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
The University of Utah
Salt Lake City, United States
Review Editor
Cardiovascular and Hematologic Drugs
University of Mississippi
Oxford, United States
Review Editor
Anti-Cancer Drugs
The University of Queensland
Brisbane, Australia
Review Editor
Neurological Drugs
University of Gothenburg
Gothenburg, Sweden
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Indonesia International Institute for Life-Sciences (i3L)
Jakarta, Indonesia
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
University of Milan
Milan, Italy
Review Editor
Anti-Cancer Drugs
Autonomous University of the State of Morelos
Cuernavaca, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
National Cancer Institute at Frederick (NIH)
Frederick, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Chung-Ang University
Seoul, Republic of Korea
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Seagen, Inc
Bothell, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Clínica de Cáncer Hereditario, Instituto Nacional de Cancerología.
Mexico City., Mexico
Review Editor
Anti-Cancer Drugs
Federal University of Alfenas
Alfenas, Brazil
Review Editor
Anti-Infective Agents
National Institute of Chemistry
Ljubljana, Slovenia
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery